KRAS ctDNA Is Predictor of Metastasis and Survival in Pancreatic Cancer
A Mayo Clinic study found that detecting KRAS ctDNA in pancreatic cancer patients signals a higher risk of cancer spread and poorer survival.
Latest Articles
Editor's Top Picks
Are we Headed for a Pandemic Redux?
Amid cases of measles, H5N1, and Mpox, a weakened public health infrastructure and anti-science sentiment could result in a pandemic redux.
Diagnostic Innovations
T-Cell Dysfunction in Post-acute Infection Syndromes Data Presented
Virax Biolabs presented data highlighting the role of T-Cell dysfunction, particularly exhaustion markers, in post-acute infection syndromes.
Equipment & Supply Spotlight
IntelliXcap S1 Reduces Strain and Streamlines Workflow
The IntelliXcap S1 from Azenta streamlines large-format tube handling with seamless adaptability, ergonomic design, and a compact footprint.
News, Know-How & Standards
Disease Detection & Understanding
Avantect Pancreatic Cancer Test Now Available
ClearNote Health has partnered with Claritev to make its Avantect Pancreatic Cancer Test available in Claritev’s PHCS and MultiPlan Networks.
